Skip to content
Home/ Thrombosis and Stroke Prevention 3rd. Edition: The Afibber's Guide to Stroke Prevention
Thrombosis and Stroke Prevention 3rd. Edition: The Afibber's Guide to Stroke Prevention

Thrombosis and Stroke Prevention 3rd. Edition: The Afibber's Guide to Stroke Prevention

No customer reviews yet ISBN 9780980924213

Do you know your risk of suffering a stroke and what you can do to prevent it?

"Hans clearly explains the body's pathways to form blood clots and to dissolve them, the medications in common use to affect these processes, and the natural alternatives that can be used to help prevent stroke. His analysis will also help to prevent heart attack and blood clots in the lungs. Read this book; it may save your life!" Sadja Greenwood MD MPH, CA

Thrombosis and Stroke Prevention covers the underlying causes and mechanisms of thrombosis (blood clot formation) and stroke and provides an in-depth review of conventional and alternative approaches to stroke prevention. This new edition adds a chapter on how to live with warfarin and presents new information about stroke risk factors and how to estimate your own risk. It provides an update of the latest research concerning natural and pharmaceutical antithrombotics including the pros and cons of the new oral anticoagulants. A final chapter discusses stroke prevention based on occluding (closing off) the left atrial appendage where the vast majority of clots associated with atrial fibrillation are generated.

" Hans Larsen's knowledge on thrombosis and stroke prevention far exceeds that of most conventional medical specialists in this area. This simple to read, cutting edge manual on natural alternatives to stroke prevention is a must read for anyone contemplating anti-coagulation therapy or simply wanting to prevent a stroke." Michael Lam MD MPH, CA

" Hans is able to explain the intricate mechanisms involved in the underlying causes of thrombosis leading to strokes, he provides us the clinical tests for each of these entities, and then offers a rational preventive means to alter this process. This book is a rich document replete with abundant references and will have a profound impact on patients attempting to understand and modify their risks for thrombosis and stroke, especially those with lone atrial fibrillation. Highly recommended, and a necessary companion to his Lone Atrial Fibrillation: Towards a Cure." Norman F. Fisher MD, CA

About the author

Product details

Pub dateApr 27, 2018
ISBN-100980924219
ISBN-139780980924213
LanguageEnglish
Last updated 2026-08-31 23:55
$21.53 $24.50 12% off
You save $2.97 · list price $24.50
In stock — ships in 24 hours with free tracking
Delivery by Monday, September 14, 2026
Qty
Sign in to Add to Saved list
Free delivery on orders over $35.
15-day returns. Any reason.
Secure checkout. We never store card details.

Readers who bought this also bought

More from Preventive Medicine
See all
Health Promotion and Health Services: Management for Change
Johnson, Anne
$89.50
Epidemic Streets: Infectious Diseases and the Rise of Preventive Medicine, 1856-1900
Hardy, Anne
$307.53
Mayo Clinic Preventive Medicine and Public Health Board Review
Varkey MD Mph Mhpe, Prathibha
$164.89
Prevention vs. Treatment: What's the Right Balance?
Everyone knows the old adage, "an ounce of prevention is worth a pound of cure," but we seem not to live by it. In the Western world's health care it is commonly observed that prevention is underfunded while treatment attracts greater overall priority. This book explores this observation by examining the actual spending on prevention, the history of health policies and structural features that affect prevention's apparent relative lack of emphasis, the values that may justify priority for treatment or for prevention, and the religious and cultural traditions that have shaped the moral relationship between these two types of care. <p/>Economists, scholars of public health and preventive medicine, philosophers, lawyers, and religious ethicists contribute specific sophisticated discussions. Their descriptions and claims lean in various directions and are often surprising. For example, the imbalance between prevention and treatment may not be as great as is often thought, and we may be spending excessively on many preventive measures just as we do on treatments compelled by the felt demands of rescue. A standard practice in health economics that disadvantages prevention, "discounting" the value of future lives, may rest on weak empirical and moral grounds. And it is an "apocalyptic" religious tradition (Seventh-day Adventism) whose members have put some of the strongest and most effective priority on long-term prevention. <p/>Prevention vs. Treatment is distinctive in carefully clarifying the nature of the empirical and moral debates about the proper balance of prevention and treatment&#x3b; the book pursues those debates from a wide range of perspectives, many not often heard from in health policy.<br>
$103.45
Quantitative Evaluation of HIV Prevention Programs
Available
$85.77
New Vaccines and Chemotherapy (1988)
Viral Vaccines Joseph L. Melnick As with history in general, the history of vaccines needs to be reexamined and updated. My task is to look back to see what has been successful and to look forward to see what remains to be accomplished in the prevention of viral diseases by vaccines. Also, I shall refer to the pertinent material discussed at two recent conferences of the Institute of Medicine, National Academy of Sciences, on virus vaccines under development and their target populations in the United States (1985b) and in developing countries (1986). These reports, plus a third on Vaccine Supply and Innovation (1985a), should be required reading for all those in both the public and the private sector who have a responsibility or interest in vaccines for the prevention of human disease. It has been through the development and use of vaccines that many viral diseases have been brought under control. The vaccines consist either of infectious living attenu- ated viruses or of noninfectious killed viruses or subviral antigens. When we look at the record, it is the live vaccines that have given the great successes in controlling diseases around the world. Examples are smallpox, yellow fever, poliomyelitis, measles, mumps, and rubella.
$177.01